
Lewy Body Dementia Global Market Report 2025
Description
Lewy Body Dementia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lewy body dementia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for lewy body dementia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lewy body dementia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Diagnosis: Clinical Diagnosis; Biomarker-Based Diagnosis
2) By Medication: Cholinesterase Inhibitors; Antipsychotics; Antidepressants; Other Medications
3) By End-User: Hospitals; Specialty Clinics; Long-Term Care Facilities; Other End-Users
Subsegments:
1) By Clinical Diagnosis: Neuropsychological Testing; Neurological Examination; Medical History Review; Cognitive Function Assessment
2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers; Imaging Biomarkers (PET, MRI); Genetic Biomarkers; Blood-Based Biomarkers
Companies Mentioned: Eli Lilly and Company; Mayo Foundation for Medical Education and Research; Eisai Co. Ltd.; Sumitomo Dainippon Pharma Co. Ltd.; Georgetown University Medical Center
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on lewy body dementia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lewy body dementia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lewy body dementia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Diagnosis: Clinical Diagnosis; Biomarker-Based Diagnosis
2) By Medication: Cholinesterase Inhibitors; Antipsychotics; Antidepressants; Other Medications
3) By End-User: Hospitals; Specialty Clinics; Long-Term Care Facilities; Other End-Users
Subsegments:
1) By Clinical Diagnosis: Neuropsychological Testing; Neurological Examination; Medical History Review; Cognitive Function Assessment
2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers; Imaging Biomarkers (PET, MRI); Genetic Biomarkers; Blood-Based Biomarkers
Companies Mentioned: Eli Lilly and Company; Mayo Foundation for Medical Education and Research; Eisai Co. Ltd.; Sumitomo Dainippon Pharma Co. Ltd.; Georgetown University Medical Center
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Lewy Body Dementia Market Characteristics
- 3. Lewy Body Dementia Market Trends And Strategies
- 4. Lewy Body Dementia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Lewy Body Dementia Growth Analysis And Strategic Analysis Framework
- 5.1. Global Lewy Body Dementia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Lewy Body Dementia Market Growth Rate Analysis
- 5.4. Global Lewy Body Dementia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Lewy Body Dementia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Lewy Body Dementia Total Addressable Market (TAM)
- 6. Lewy Body Dementia Market Segmentation
- 6.1. Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Clinical Diagnosis
- Biomarker-Based Diagnosis
- 6.2. Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cholinesterase Inhibitors
- Antipsychotics
- Antidepressants
- Other Medications
- 6.3. Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Long-Term Care Facilities
- Other End-Users
- 6.4. Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neuropsychological Testing
- Neurological Examination
- Medical History Review
- Cognitive Function Assessment
- 6.5. Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cerebrospinal Fluid (CSF) Biomarkers
- Imaging Biomarkers (PET, MRI)
- Genetic Biomarkers
- Blood-Based Biomarkers
- 7. Lewy Body Dementia Market Regional And Country Analysis
- 7.1. Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Lewy Body Dementia Market
- 8.1. Asia-Pacific Lewy Body Dementia Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Lewy Body Dementia Market
- 9.1. China Lewy Body Dementia Market Overview
- 9.2. China Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Lewy Body Dementia Market
- 10.1. India Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Lewy Body Dementia Market
- 11.1. Japan Lewy Body Dementia Market Overview
- 11.2. Japan Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Lewy Body Dementia Market
- 12.1. Australia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Lewy Body Dementia Market
- 13.1. Indonesia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Lewy Body Dementia Market
- 14.1. South Korea Lewy Body Dementia Market Overview
- 14.2. South Korea Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Lewy Body Dementia Market
- 15.1. Western Europe Lewy Body Dementia Market Overview
- 15.2. Western Europe Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Lewy Body Dementia Market
- 16.1. UK Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Lewy Body Dementia Market
- 17.1. Germany Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Lewy Body Dementia Market
- 18.1. France Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Lewy Body Dementia Market
- 19.1. Italy Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Lewy Body Dementia Market
- 20.1. Spain Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Lewy Body Dementia Market
- 21.1. Eastern Europe Lewy Body Dementia Market Overview
- 21.2. Eastern Europe Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Lewy Body Dementia Market
- 22.1. Russia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Lewy Body Dementia Market
- 23.1. North America Lewy Body Dementia Market Overview
- 23.2. North America Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Lewy Body Dementia Market
- 24.1. USA Lewy Body Dementia Market Overview
- 24.2. USA Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Lewy Body Dementia Market
- 25.1. Canada Lewy Body Dementia Market Overview
- 25.2. Canada Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Lewy Body Dementia Market
- 26.1. South America Lewy Body Dementia Market Overview
- 26.2. South America Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Lewy Body Dementia Market
- 27.1. Brazil Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Lewy Body Dementia Market
- 28.1. Middle East Lewy Body Dementia Market Overview
- 28.2. Middle East Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Lewy Body Dementia Market
- 29.1. Africa Lewy Body Dementia Market Overview
- 29.2. Africa Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Lewy Body Dementia Market Competitive Landscape And Company Profiles
- 30.1. Lewy Body Dementia Market Competitive Landscape
- 30.2. Lewy Body Dementia Market Company Profiles
- 30.2.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sumitomo Dainippon Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Georgetown University Medical Center Overview, Products and Services, Strategy and Financial Analysis
- 31. Lewy Body Dementia Market Other Major And Innovative Companies
- 31.1. Alzheimer's Society
- 31.2. BioArctic AB
- 31.3. Annovis Bio Inc.
- 31.4. Sun Pharma Advanced Research Company Limited
- 31.5. Voyager Therapeutics Inc.
- 31.6. Cognition Therapeutics
- 31.7. Athira Pharma
- 31.8. Allergan plc
- 31.9. Inhibikase Therapeutics
- 31.10. CuraSen Therapeutics Inc.
- 31.11. CervoMed Inc.
- 31.12. AC Immune SA
- 31.13. ProMIS Neurosciences Inc.
- 31.14. Aptinyx Inc.
- 31.15. EIP Pharma Inc.
- 32. Global Lewy Body Dementia Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Lewy Body Dementia Market
- 34. Recent Developments In The Lewy Body Dementia Market
- 35. Lewy Body Dementia Market High Potential Countries, Segments and Strategies
- 35.1 Lewy Body Dementia Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Lewy Body Dementia Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Lewy Body Dementia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.